Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer
Clinical trial NCT04294784 · TERMINATED
Trial details
- NCT number
- NCT04294784
- Sponsor
- Huazhong University of Science and Technology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-03
- Primary completion
- 2023-11-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.